Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Gastrointest Surg. 2013 Aug 14;17(10):1774–1783. doi: 10.1007/s11605-013-2302-6

Table 2.

Characteristics of 828 patients by scanning intensity Characteristics of 828 patients by scanning intensity among patients who survived for more than 2 years and did not have a second procedure during these years

Zero to one scan in 2 years (n=230) Regular, periodic scanning over 2 years
P value
One to two scans/year (n=455) Three to four scans/year (n=143)
Age, n (%)
 66–69 51 (22.2) 135 (29.7) 48 (33.6) 0.10
 70–74 76 (33.0) 145 (31.9) 47 (32.9)
 75+ 103 (44.8) 175 (38.5) 48 (33.6)
Male gender; n (%) 142 (61.7) 298 (65.5) 94 (65.7) 0.59
White race; n (%) 152 (66.1) 292 (64.2) 85 (59.4) 0.42
Urban location 202 (87.8) 413 (90.8) 132 (92.3) 0.16
Top two quintiles of SES 79 (34.4) 219 (48.1) 67 (46.9) <0.001
Geographic location
 Northeast 40 (17.4) 98 (21.5) 37 (25.9) 0.18
 West 140 (60.9) 263 (57.8) 86 (60.1)
 Midwest/South 50 (21.7) 94 (20.7) 20 (14.0)
SEER historic stage of HCC
 Localized/in situ 180 (79.1) 353 (77.6) 98 (68.5) 0.15
 Regional 33 (14.4) 69 (15.2) 33 (23.1)
 No stage recorded 15 (6.5) 33 (7.3) 12 (8.4)
Any comorbidity 133 (57.8) 263 (57.8) 83 (58.0) 0.99
First procedure following diagnosis
 Hepatectomy 125 (54.4) 198 (43.5) 31 (21.7) <0.001
 Ablation 76 (33.0) 210 (46.2) 86 (60.1)
 IAT 29 (12.6) 47 (10.3) 26 (18.2)
Period of treatment
 1998–2002 131 (57.0) 292 (64.2) 91 (63.6) 0.17
 2003–2007 99 (43.0) 163 (35.8) 52 (36.4)
Physician consultation
 Surgeon 156 (67.8) 303 (66.6) 92 (64.3) 0.79
 Medical oncologist 129 (56.1) 274 (60.2) 87 (60.8) 0.53
 IR 105 (45.7) 236 (51.9) 94 (65.7) <0.001